Oral rivaroxaban versus enoxapa-rin with vitamin K antagonist for the treatment of symptomatic venous throm-boembolism in patients with cancer (EINSTEIN-DVT and EINSTEIN-PE): a pooled subgroup analysis of two randomised controlled trials - Prins, MH; Lensing, AWA; Brighton, TA (The Lancet Hae-matology, 2014)